Syntara Limited has released a press release.
Quarterly Shareholder Update March 2017
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Syntara
- Synairgen Collaboration Progress
- Chairmans Address to Shareholders
- Research Collaboration with Woolcock Institute
- S&P DJ Indicies Announces March Quarterly Rebalance
- Pharmaxis Announces Russian Approval for Bronchitol
Later from Syntara
- Appendix 4C - quarterly cash flow
- Pharmaxis Appoints Chiesi as Bronchitol Distributor in Italy
- Pharmaxis Set to Generate Further Euro 10m Milestone Payment
- Pharmaxis Announces Results of Pivotal CF Clinical Trial
- Appendix 4C - quarterly June 2017
Follow Syntara into a list and get an email when it puts out news.
Follow Syntara